9-Methoxy-6-{4-[2-(piperazin-1-yl)acetyl]piperazin-1-yl}-11Hindeno[1,2-c]quinolin-11-one

ID: ALA3585494

PubChem CID: 101885917

Max Phase: Preclinical

Molecular Formula: C27H29N5O3

Molecular Weight: 471.56

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)C(=O)c1c-2c(N2CCN(C(=O)CN3CCNCC3)CC2)nc2ccccc12

Standard InChI:  InChI=1S/C27H29N5O3/c1-35-18-6-7-19-21(16-18)26(34)24-20-4-2-3-5-22(20)29-27(25(19)24)32-14-12-31(13-15-32)23(33)17-30-10-8-28-9-11-30/h2-7,16,28H,8-15,17H2,1H3

Standard InChI Key:  AFTYTORWLILVGK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 35 40  0  0  0  0  0  0  0  0999 V2000
    3.5632   -2.4942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5431   -1.4253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0754    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0934   -2.2270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5812   -0.7794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4942    0.2895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0934    1.7370    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6236    2.0488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1433    3.4707    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3241    3.7793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7907    5.2049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7893    6.3217    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6786    6.0130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1451    4.5874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0891   -0.4677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3340    0.9353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690   -1.3585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2938   -0.4677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8484    0.9353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8728    2.0488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3426    1.7370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8103    0.2672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7636   -0.8240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2691   -0.0829    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6106   -1.2332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0528   -2.5584    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2532    7.7491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4271    7.9981    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2497    8.8651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7136   10.2924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2877   11.4093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1788   12.8349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6466   13.1437    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6480   12.0269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1815   10.6013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8 16  1  0
 15  5  1  0
  9 10  1  0
  9 14  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
  8  9  1  0
 15 16  2  0
 16 19  1  0
 18 17  1  0
 17 15  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 22 24  1  0
 24 25  1  0
 17 26  2  0
 12 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  0
 30 31  1  0
 30 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
M  END

Associated Targets(Human)

Detroit 551 (346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1299 (3248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGS (1999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SAS (201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 471.56Molecular Weight (Monoisotopic): 471.2270AlogP: 2.01#Rotatable Bonds: 4
Polar Surface Area: 78.01Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.92CX LogP: 2.24CX LogD: 0.72
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.49Np Likeness Score: -0.84

References

1. Tseng C, Tzeng C, Chiu C, Yang C, Lu P, Chou C, Liu C, Chen Y.  (2014)  Synthesis and antiproliferative evaluation of 9-methoxy-6-(piperazin-1-yl)-11H-indeno[1,2-c]quinoline-11-one derivatives. Part 4,  (7): [10.1039/C4MD00133H]

Source